TG Therapeutics, Inc. (TGTX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$28.39
Day's range
$29.42

TG Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 22.05 M $1.21 B   -0.91% 15.55%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 7.96 M $437.50 M   -3.76% 5.62%
STATE STREET CORP 08/07/2026 7.79 M $427.79 M   -9.98% 5.49%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 6.15 M $337.85 M   -6.87% 4.34%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 3.64 M $200.14 M   4.07% 2.57%
D. E. SHAW & CO., INC. 08/14/2026 3.40 M $186.84 M   476.36% 2.40%
SOLEUS CAPITAL MANAGEMENT, L.P. 08/11/2026 2.93 M $160.86 M   -27.34% 2.07%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 2.77 M $152.06 M   337.41% 1.95%
CLEARBRIDGE INVESTMENTS, LLC 08/13/2026 2.65 M $145.60 M   -17.46% 1.87%
CONGRESS ASSET MANAGEMENT CO /MA 07/07/2026 2.60 M $142.85 M   19.93% 1.83%
TWO SIGMA INVESTMENTS, LP 08/14/2026 2.47 M $135.65 M   60.08% 1.74%
GOLDMAN SACHS GROUP INC 08/14/2026 2.31 M $127.15 M   1.16% 1.63%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 1.79 M $98.12 M   2.21% 1.26%
JANE STREET GROUP, LLC 08/14/2026 1.75 M $96.29 M   -14.16% 1.24%
NUVEEN, LLC 08/11/2026 1.63 M $89.33 M   12.36% 1.15%
MORGAN STANLEY 08/13/2026 1.60 M $88.00 M   13.74% 1.13%
HOOD RIVER CAPITAL MANAGEMENT LLC 08/14/2026 1.60 M $87.93 M   2.00% 1.13%
NORTHERN TRUST CORP 08/13/2026 1.54 M $84.45 M   6.55% 1.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 1.36 M $74.76 M   38.87% 0.96%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 1.31 M $72.14 M   1.39% 0.93%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 1.31 M $72.14 M   100.00% 0.93%
BANK OF AMERICA CORP /DE/ 08/14/2026 1.31 M $71.96 M   -10.37% 0.92%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 1.21 M $66.51 M   11.59% 0.85%
FMR LLC 08/13/2026 1.02 M $55.97 M   263.28% 0.72%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 961.75 K $52.84 M   -0.71% 0.68%
BARCLAYS PLC 08/14/2026 957.85 K $52.62 M   721.08% 0.68%
BANK OF NEW YORK MELLON CORP 08/06/2026 900.48 K $49.47 M   1.49% 0.64%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 860.50 K $47.28 M   -10.09% 0.61%
VOYA INVESTMENT MANAGEMENT LLC 08/12/2026 819.25 K $45.01 M   95.24% 0.58%
WOODLINE PARTNERS LP 08/14/2026 715.50 K $39.31 M   0.00% 0.50%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 679.30 K $37.32 M   99.27% 0.48%
PRINCIPAL FINANCIAL GROUP INC 08/04/2026 645.34 K $35.46 M   -3.03% 0.46%
HRT FINANCIAL LP 08/14/2026 622.60 K $34.21 M   330.95% 0.44%
RAYMOND JAMES FINANCIAL INC 08/14/2026 620.28 K $34.08 M   45.48% 0.44%
CITADEL ADVISORS LLC 09/02/2026 537.17 K $29.51 M   -72.06% 0.38%
PENN CAPITAL MANAGEMENT COMPANY, LLC 07/30/2026 536.07 K $29.51 M   -1.09% 0.38%
OPALEYE MANAGEMENT INC. 08/14/2026 535.00 K $29.39 M   0.00% 0.38%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 525.60 K $28.88 M   12.36% 0.37%
BANK OF MONTREAL /CAN/ 08/12/2026 515.98 K $28.35 M   0.13% 0.36%
UBS GROUP AG 08/13/2026 515.16 K $28.30 M   1.88% 0.36%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 478.27 K $26.28 M   697.57% 0.34%
PUBLIC SECTOR PENSION INVESTMENT BOARD 08/13/2026 452.82 K $24.88 M   -7.07% 0.32%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 442.29 K $24.30 M   28.50% 0.31%
BRIDGEWATER ASSOCIATES, LP 08/14/2026 429.90 K $23.62 M   38.05% 0.30%
OCCAM CREST MANAGEMENT LP 08/14/2026 425.00 K $22.73 M   -26.34% 0.30%
NEW YORK STATE COMMON RETIREMENT FUND 07/29/2026 408.26 K $22.43 M   1.59% 0.29%
JPMORGAN CHASE & CO 08/12/2026 407.50 K $23.08 M   170.72% 0.29%
INVESCO LTD. 08/14/2026 406.86 K $22.35 M   -43.57% 0.29%
683 CAPITAL MANAGEMENT, LLC 08/14/2026 389.08 K $21.38 M   -34.05% 0.27%
CITIGROUP INC 08/03/2026 388.09 K $21.32 M   9.64% 0.27%

TG Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 558 institutional investors and hedge funds held shares of TG Therapeutics Inc. The most heavily invested institutionals were:

BlackRock, Inc.: 22.05 M

VANGUARD PORTFOLIO MANAGEMENT LLC: 7.96 M

STATE STREET CORP: 7.79 M

VANGUARD CAPITAL MANAGEMENT LLC: 6.15 M

GEODE CAPITAL MANAGEMENT, LLC: 3.64 M

D. E. Shaw & Co., Inc.: 3.4 M

79.42% of TG Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 149.97 M shares in the last 24 months. This purchase volume represents approximately $4.38 B in transactions.